MarketResearchReports.Biz
presents this most up-to-date research on “ Retinitis Pigmentosa
(Retinitis) Global Clinical Trials Review, H2, 2016 ”
GlobalData's
clinical trial report, Retinitis
Pigmentosa (Retinitis)
Global Clinical Trials Review, H2, 2016" provides an overview of
Retinitis Pigmentosa (Retinitis) clinical trials scenario. This
report provides top line data relating to the clinical trials on
Retinitis Pigmentosa (Retinitis). Report includes an overview of
trial numbers and their average enrollment in top countries conducted
across the globe. The report offers coverage of disease clinical
trials by region, country (G7 & E7), phase, trial status, end
points status and sponsor type. Report also provides prominent drugs
for in-progress trials (based on number of ongoing trials).
GlobalData Clinical Trial Reports are generated using GlobalDatas
proprietary database - Pharma eTrack Clinical trials database.
Clinical trials are collated from 80+ different clinical trial
registries, conferences, journals, news etc across the globe.
Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download
Sample copy of this Report at
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Five Countries Contributing
to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Five Countries Contributing
to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to
Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Retinitis Pigmentosa (Retinitis) to
Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Retinitis Pigmentosa (Retinitis) to
Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Top Companies Participating in
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on
Retinitis Pigmentosa (Retinitis) 30
Aug 10, 2016: Spark
Therapeutics Announces New Positive Data from Continuation of Phase 3
Trial of Voretigene Neparvovec 30
Jul 22, 2016: ReNeuron Group:
Publication of positive pre-clinical data from retinal stem cells 31
Jul 01, 2016: Spark
Therapeutics Announces Publication of Positive Follow-Up Data from
Phase 1 Trial of Voretigene Neparvovec in The Lancet 31
Clinical Trial Profile
Snapshots 33
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment